Does the addition of a gonadotropin-releasing hormone agonist improve the pregnancy rate in intrauterine insemination? A prospective controlled trial

References

• Sahakyan M, Harlow B L, Hornstein M D. Influence of age, diagnosis, and cycle number on pregnancy rates with gonadotropin-induced controlled ovarian hyperstimulation and intrauterine insemination. Fertil Steril 1999; 72: 500–504
   PubMed Web of Science ®Google Scholar
• Duran H E, Morshedi M, Kruger T, Oehninger S. Intrauterine insemination: a systematic review on determinants of success. Hum Reprod Update 2002; 8: 373–384
   PubMed Web of Science ®Google Scholar
• Nuojua-Huttunen S, Tomas C, Bloigu R, Tuomivaara L, Martikainen H. Intrauterine insemination treatment in subfertility: an analysis of factors affecting outcome. Hum Reprod 1999; 14: 698–703
   PubMed Web of Science ®Google Scholar
• Dickey R P, Taylor S N, Lu P Y, Sartor B M, Rye P H, Pyrzak R. Effect of diagnosis, age, sperm quality, and number of preovulatory follicles on the outcome of multiple cycles of clomiphene citrate–intrauterine insemination. Fertil Steril 2002; 78: 1088–1095
   PubMed Web of Science ®Google Scholar
• Houmard B S, Juang M P, Soules M R, Fujimoto V Y. Factors influencing pregnancy rates with a combined clomiphene citrate/gonadotropin protocol for non-assisted reproductive technology fertility treatment. Fertil Steril 2002; 77: 384–386
   PubMed Web of Science ®Google Scholar
• Kaplan P F, Katz S L, Thompson A K, Freund R D. Cycle fecundity in controlled ovarian hyperstimulation and intrauterine insemination. Influence of the number of mature follicles at hCG administration. J Reprod Med 2002; 47: 35–39
   Web of Science ®Google Scholar
• Ragni G, Somigliana E, Vegetti W. Timing of intrauterine insemination: where are we?. Fertil Steril 2004; 82: 25–26
   PubMed Web of Science ®Google Scholar
• Loumaye E. The control of endogenous secretion of LH by gonadotrophin-releasing hormone agonists during ovarian hyperstimulation for in-vitro fertilization and embryo transfer. Hum Reprod 1990; 5: 357–376
   PubMed Web of Science ®Google Scholar
• Hughes S M, Huang Z H, Matson P L, Buck P, Lieberman B A, Morris I D. Clinical and endocrinological changes in women following ovulation induction using buserelin acetate/human menopausal gonadotrophin augmented with biosynthetic human growth hormone. Hum Reprod 1992; 7: 770–775
   PubMed Web of Science ®Google Scholar
• Cohlen B J. Should we continue performing intrauterine inseminations in the year 2004?. Gynecol Obstet Invest 2005; 59: 3–13
   PubMed Web of Science ®Google Scholar
• Mansour R T, Serour G I, Aboulghar M A. Intrauterine insemination with washed capacitated sperm cells in the treatment of male factor, cervical factor and unexplained infertility. Asia Oceania J Obstet Gynaecol 1989; 15: 151–154
   PubMedGoogle Scholar
• Aboulghar M, Mansour R, Serour G, Abdrazek A, Amin Y, Rhodes C. Controlled ovarian hyperstimulation and intrauterine insemination for treatment of unexplained infertility should be limited to a maximum of three trials. Fertil Steril 2001; 75: 88–91
   PubMed Web of Science ®Google Scholar
• Hughes E G. Stimulated intra-uterine insemination is not a natural choice for the treatment of unexplained subfertility. ‘Effective treatment’ or ‘not a natural choice’?. Hum Reprod 2003; 18: 912–914
   PubMed Web of Science ®Google Scholar
• Pandian Z, Bhattacharya S, Vale L, Templeton A. In vitro fertilization for unexplained subfertility. Cochrane Database Syst Rev 2005, 2, CD003357
   PubMed Web of Science ®Google Scholar
• Campana A, Sakkas D, Stalberg A, Bianchi P G, Comte I, Pache T. Intrauterine insemination: evaluation of the results according to the women's age, sperm quality, total sperm count per insemination and life table analysis. Hum Reprod 1996; 11: 732–736
   PubMed Web of Science ®Google Scholar
• Hughes E G. The effectiveness of ovulation induction and intrauterine insemination in the treatment of persistent infertility: a meta-analysis. Hum Reprod 1997; 12: 1865–1872
   PubMed Web of Science ®Google Scholar
• Dmowski W P, Pry M, Ding J, Rana N. Cycle-specific and fecundity in patients with endometriosis who are undergoing controlled ovarian hyperstimulation–intrauterine insemination or in vitro fertilization–embryo transfer. Fertil Steril 2002; 78: 750–756
   PubMed Web of Science ®Google Scholar
• Gomez-Palomares J L, Julia B, Acevedo-Martin B, Martinez-Burgos M, Hernandez E R, Ricciarelli E. Timing ovulation for intrauterine insemination with a GnRH antagonist. Hum Reprod 2005; 20: 368–372
   PubMed Web of Science ®Google Scholar
• Williams R S, Hillard J B, De Vane G, Yeko T, Kipersztok S, Rhoton-Vlasak A, Sistrom C. A randomized, multicenter study comparing the efficacy of recombinant FSH vs recombinant FSH with Ganirelix during superovulation/IUI therapy. Am J Obstet Gynecol 2004; 191: 648–651
   PubMed Web of Science ®Google Scholar
• Checa M A, Prat M, Robles A, Carreras R. Use of gonadotropin-releasing hormone antagonists to overcome the drawbacks of intrauterine insemination on weekends. Fertil Steril 2006; 85: 573–577
   PubMed Web of Science ®Google Scholar
• Duffy D A, Manzi D, Benadiva C, Maier D, Saunders M, Nulsen J. Impact of leuprolide acetate on luteal phase function in women undergoing controlled ovarian hyperstimulation and intrauterine insemination. Fertil Steril 2006; 85: 407–411
   PubMed Web of Science ®Google Scholar
• Lambalk C B, Leader A, Olivennes F, Fluker M R, Andersen A N, Ingerslev J, Khalaf Y, Avril C, Belaisch-Allart J, Roulier R, et al. Treatment with the GnRH antagonist ganirelix prevents premature LH rises and luteinization in stimulated intrauterine insemination: results of a double-blind, placebo-controlled, multicentre trial. Hum Reprod 2006; 21: 632–639
   PubMed Web of Science ®Google Scholar
• Hall J E. Gonadotropin-releasing hormone antagonists: effects on the ovarian follicle and corpus luteum. Clin Obstet Gynecol 1993; 36: 744–752
   PubMed Web of Science ®Google Scholar
• Al-Inany H G, Abou-Setta A M, Aboulghar M. Gonadotrophin-releasing hormone antagonists for assisted conception. Cochrane Database Syst Rev 2006, 3, CD001750
   Web of Science ®Google Scholar